This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (448)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Cardiovascular System  • Review  • Congestive Heart Failure/ Cardiomyopathy  • Alert me on articles by topic  Social Bookmarking   What's this?

A Systematic Review

Barry J. Maron, MD

JAMA. 2002;287:1308-1320.

Context  Throughout the past 40 years, a vast and sometimes contradictory literature has accumulated regarding hypertrophic cardiomyopathy (HCM), a genetic cardiac disease caused by a variety of mutations in genes encoding sarcomeric proteins and characterized by a broad and expanding clinical spectrum.

Objectives  To clarify and summarize the relevant clinical issues and to profile rapidly evolving concepts regarding HCM.

Data Sources  Systematic analysis of the relevant HCM literature, accessed through MEDLINE (1966-2000), bibliographies, and interactions with investigators.

Study Selection and Data Extraction  Diverse information was assimilated into a rigorous and objective contemporary description of HCM, affording greatest weight to prospective, controlled, and evidence-based studies.

Data Synthesis  Hypertrophic cardiomyopathy is a relatively common genetic cardiac disease (1:500 in the general population) that is heterogeneous with respect to disease-causing mutations, presentation, prognosis, and treatment strategies. Visibility attached to HCM relates largely to its recognition as the most common cause of sudden death in the young (including competitive athletes). Clinical diagnosis is by 2-dimensional echocardiographic identification of otherwise unexplained left ventricular wall thickening in the presence of a nondilated cavity. Overall, HCM confers an annual mortality rate of about 1% and in most patients is compatible with little or no disability and normal life expectancy. Subsets with higher mortality or morbidity are linked to the complications of sudden death, progressive heart failure, and atrial fibrillation with embolic stroke. Treatment strategies depend on appropriate patient selection, including drug treatment for exertional dyspnea (-blockers, verapamil, disopyramide) and the septal myotomy-myectomy operation, which is the standard of care for severe refractory symptoms associated with marked outflow obstruction; alcohol septal ablation and pacing are alternatives to surgery for selected patients. High-risk patients may be treated effectively for sudden death prevention with the implantable cardioverter-defibrillator.

Conclusions  Substantial understanding has evolved regarding the epidemiology and clinical course of HCM, as well as novel treatment strategies that may alter its natural history. An appreciation that HCM, although an important cause of death and disability at all ages, does not invariably convey ominous prognosis and is compatible with normal longevity should dictate a large measure of reassurance for many patients.

Author Affiliation: Minneapolis Heart Institute Foundation, Minneapolis, Minn.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

March 13, 2002
JAMA. 2002;287(10):1333-1334.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening
Gupta et al.
Sports Health: A Multidisciplinary Approach 2009;1:500-507.
ABSTRACT | FULL TEXT  

Transgenerational genetic effects on phenotypic variation and disease risk
Nadeau
Hum Mol Genet 2009;18:R202-R210.
ABSTRACT | FULL TEXT  

Unusual cause of stroke in hypertrophic cardiomyopathy
Basavarajaiah et al.
Heart 2009;95:1592-1592.
FULL TEXT  

Regional abnormalities of myocardial deformation in patients with hypertrophic cardiomyopathy: correlations with delayed enhancement in cardiac magnetic resonance
Ghio et al.
Eur J Heart Fail 2009;11:952-957.
ABSTRACT | FULL TEXT  

Identification of Unexpected Nonatherosclerotic Cardiovascular Disease With Coronary CT Angiography
Knickelbine et al.
J Am Coll Cardiol Img 2009;2:1085-1092.
ABSTRACT | FULL TEXT  

Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening
Maron
Br. J. Sports. Med. 2009;43:649-656.
ABSTRACT | FULL TEXT  

Electrocardiographic screening in athletes: the time is now for universal screening
Papadakis and Sharma
Br. J. Sports. Med. 2009;43:663-668.
ABSTRACT | FULL TEXT  

Return to play? Practical considerations for young athletes with cardiovascular disease
Anderson and Vetter
Br. J. Sports. Med. 2009;43:690-695.
ABSTRACT | FULL TEXT  

The case for myocardial ischemia in hypertrophic cardiomyopathy.
Maron et al.
J Am Coll Cardiol 2009;54:866-875.
ABSTRACT | FULL TEXT  

Solution Structure of Human Cardiac Troponin C in Complex with the Green Tea Polyphenol, (-)-Epigallocatechin 3-Gallate
Robertson et al.
J. Biol. Chem. 2009;284:23012-23023.
ABSTRACT | FULL TEXT  

Ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy
Carrier et al.
Cardiovasc Res 2009;0:cvp247v2-cvp247.
ABSTRACT | FULL TEXT  

The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy.
Maron et al.
J Am Coll Cardiol 2009;54:191-200.
ABSTRACT | FULL TEXT  

Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy.
Bos et al.
J Am Coll Cardiol 2009;54:201-211.
ABSTRACT | FULL TEXT  

Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
Maron et al.
J Am Coll Cardiol 2009;54:220-228.
ABSTRACT | FULL TEXT  

Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study.
Sorajja et al.
J Am Coll Cardiol 2009;54:234-241.
ABSTRACT | FULL TEXT  

A Functional and Structural Study of Troponin C Mutations Related to Hypertrophic Cardiomyopathy
Pinto et al.
J. Biol. Chem. 2009;284:19090-19100.
ABSTRACT | FULL TEXT  

Prevalence and significance of T-wave inversions in predominantly Caucasian adolescent athletes
Papadakis et al.
Eur Heart J 2009;30:1728-1735.
ABSTRACT | FULL TEXT  

Expression Patterns of Cardiac Myofilament Proteins: Genomic and Protein Analysis of Surgical Myectomy Tissue From Patients With Obstructive Hypertrophic Cardiomyopathy
Theis et al.
Circ Heart Fail 2009;2:325-333.
ABSTRACT | FULL TEXT  

Myocardial bridging and sudden death in hypertrophic cardiomyopathy: Salome drops another veil
Olivotto et al.
Eur Heart J 2009;30:1549-1550.
FULL TEXT  

Overlapping Phenotypes: Left Ventricular Noncompaction and Hypertrophic Cardiomyopathy
Kelley-Hedgepeth et al.
Circulation 2009;119:e588-e589.
FULL TEXT  

Inducible Malignant Ventricular Tachyarrhythmia in a Patient With Genotyped Hypertrophic Cardiomyopathy in Absence of Left Ventricular Hypertrophy or Enlargement
Ariyarajah et al.
Circulation 2009;119:e543-e544.
FULL TEXT  

ST-segment depression as a risk factor in hypertrophic cardiomyopathy
Haghjoo et al.
Europace 2009;11:643-649.
ABSTRACT | FULL TEXT  

Left ventricular hypertrophy in athletes
Rawlins et al.
Eur J Echocardiogr 2009;10:350-356.
ABSTRACT | FULL TEXT  

Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy
Spirito et al.
Circulation 2009;119:1703-1710.
ABSTRACT | FULL TEXT  

Multiple Mutations in Genetic Cardiovascular Disease: A Marker of Disease Severity?
Kelly and Semsarian
Circ Cardiovasc Genet 2009;2:182-190.
FULL TEXT  

Advances in the prevention of sudden cardiac death in the young
Shephard and Semsarian
Ther Adv Cardiovasc Dis 2009;3:145-155.
ABSTRACT  

Immediate improvement in coronary flow reserve after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy
Jaber et al.
Heart 2009;95:564-569.
ABSTRACT | FULL TEXT  

Influence of the pattern of hypertrophy on left ventricular twist in hypertrophic cardiomyopathy
van Dalen et al.
Heart 2009;95:657-661.
ABSTRACT | FULL TEXT  

Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice
Abraham et al.
Cardiovasc Res 2009;82:84-92.
ABSTRACT | FULL TEXT  

Resolution of Established Cardiac Hypertrophy and Fibrosis and Prevention of Systolic Dysfunction in a Transgenic Rabbit Model of Human Cardiomyopathy Through Thiol-Sensitive Mechanisms
Lombardi et al.
Circulation 2009;119:1398-1407.
ABSTRACT | FULL TEXT  

Recent advances in diagnosis and management of hypertrophic cardiomyopathy
Siswanto and Aryani
Heart Asia 2009;2009:1-4.
ABSTRACT | FULL TEXT  

Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice
Kerrick et al.
FASEB J. 2009;23:855-865.
ABSTRACT | FULL TEXT  

Hypertrophic cardiomyopathy: current understanding and treatment objectives
Soor et al.
J. Clin. Pathol. 2009;62:226-235.
ABSTRACT | FULL TEXT  

AJR Teaching File: Asymptomatic Man with Giant Negative T Waves on ECG
Attili et al.
Am. J. Roentgenol. 2009;192:S57-S61.
FULL TEXT  

How should hypertrophic cardiomyopathy be classified?: What's in a Name? Dilemmas in Nomenclature Characterizing Hypertrophic Cardiomyopathy and Left Ventricular Hypertrophy
Maron et al.
Circ Cardiovasc Genet 2009;2:81-86.
FULL TEXT  

Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging
Esposito et al.
Heart 2009;95:228-233.
ABSTRACT | FULL TEXT  

Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis
Cambronero et al.
Eur Heart J 2009;0:ehn538v1-13.
ABSTRACT | FULL TEXT  

Hypertrophic cardiomyopathy without hypertrophy: an emerging pre-clinical subgroup composed of genetically affected family members.
Maron and Ho
J Am Coll Cardiol Img 2009;2:65-68.
FULL TEXT  

The Effects of Candesartan on Left Ventricular Hypertrophy and Function in Nonobstructive Hypertrophic Cardiomyopathy: A Pilot, Randomized Study
Penicka et al.
J. Mol. Diagn. 2009;11:35-41.
ABSTRACT | FULL TEXT  

A Pattern-based Approach to Assessment of Delayed Enhancement in Nonischemic Cardiomyopathy at MR Imaging1
Cummings et al.
RadioGraphics 2009;29:89-103.
ABSTRACT | FULL TEXT  

CHAPTER 18 Myocardial Disease
Hess et al.
ESC Textbook of Cardiovascular Medicine 2009;2:med-9780199566990-chapter-med-9780199566990-chapter.
ABSTRACT | FULL TEXT  

CHAPTER 26 Syncope
Brignole et al.
ESC Textbook of Cardiovascular Medicine 2009;2:med-9780199566990-chapter-med-9780199566990-chapter.
ABSTRACT | FULL TEXT  

Standards for LVH in Elite Athletes
Bernhardt
AAP Grand Rounds 2008;20:65-65.
FULL TEXT  

Implantable Cardioverter-Defibrillator Therapy for Primary Prevention of Sudden Death After Alcohol Septal Ablation of Hypertrophic Cardiomyopathy
Cuoco et al.
J Am Coll Cardiol 2008;52:1718-1723.
ABSTRACT | FULL TEXT  

Resection-Plication-Release for Hypertrophic Cardiomyopathy: Clinical and Echocardiographic Follow-Up
Balaram et al.
Ann. Thorac. Surg. 2008;86:1539-1545.
ABSTRACT | FULL TEXT  

Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies.
Afonso et al.
J Am Coll Cardiol Img 2008;1:787-800.
ABSTRACT | FULL TEXT  

Myocardial deformation abnormalities in paediatric hypertrophic cardiomyopathy: are all aetiologies identical?
Ganame et al.
Eur J Echocardiogr 2008;9:784-790.
ABSTRACT | FULL TEXT  

Acceleration of Crossbridge Kinetics by Protein Kinase A Phosphorylation of Cardiac Myosin Binding Protein C Modulates Cardiac Function
Tong et al.
Circ. Res. 2008;103:974-982.
ABSTRACT | FULL TEXT  

Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy
Maron et al.
Circulation 2008;118:1541-1549.
ABSTRACT | FULL TEXT  

Effect of Septal Ablation on Myocardial Relaxation and Left Atrial Pressure in Hypertrophic Cardiomyopathy: An Invasive Hemodynamic Study
Sorajja et al.
J Am Coll Cardiol Intv 2008;1:552-560.
ABSTRACT | FULL TEXT  

Bringing the obstruction back into hypertrophic cardiomyopathy
Murphy
Heart 2008;94:1249-1250.
FULL TEXT  

Exercise-induced systolic dysfunction in patients with non-obstructive hypertrophic cardiomyopathy and mutations in the cardiac troponin genes
Sakata et al.
Heart 2008;94:1282-1287.
ABSTRACT | FULL TEXT  

B-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy
Kaski et al.
Heart 2008;94:1307-1311.
ABSTRACT | FULL TEXT  

Acute effects of alcohol septal ablation on systolic and diastolic left ventricular function in patients with hypertrophic obstructive cardiomyopathy
Steendijk et al.
Heart 2008;94:1318-1322.
ABSTRACT | FULL TEXT  

Homozygous mutation of MYBPC3 associated with severe infantile hypertrophic cardiomyopathy at high frequency among the Amish
Zahka et al.
Heart 2008;94:1326-1330.
ABSTRACT | FULL TEXT  

Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future
Ommen et al.
Heart 2008;94:1276-1281.
FULL TEXT  

Preparticipation screening for cardiovascular abnormalities in young competitive athletes
Papadakis et al.
BMJ 2008;337:a1596-a1596.
FULL TEXT  

Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy
Maron et al.
Circ Heart Fail 2008;1:184-191.
ABSTRACT | FULL TEXT  

Left ventricular outflow tract obstruction in the presence of asymmetric septal hypertrophy and accessory mitral valve tissue treated with alcohol septal ablation
Kim et al.
Eur J Echocardiogr 2008;9:720-724.
ABSTRACT | FULL TEXT  

Assessment and Significance of Left Ventricular Mass by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
Olivotto et al.
J Am Coll Cardiol 2008;52:559-566.
ABSTRACT | FULL TEXT  

Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
Sorajja et al.
Circulation 2008;118:131-139.
ABSTRACT | FULL TEXT  

The Risk in Exercise Training
Foster et al.
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2008;2:279-284.
ABSTRACT  

Impact of Percutaneous Transluminal Septal Myocardial Ablation on Refractory Paroxysmal Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy
Hosokawa et al.
ANGIOLOGY 2008;59:329-334.
ABSTRACT  

Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy
Saumarez et al.
Eur Heart J 2008;29:1653-1661.
ABSTRACT | FULL TEXT  

Spatial Relationship Between Coronary Microvascular Dysfunction and Delayed Contrast Enhancement in Patients with Hypertrophic Cardiomyopathy
Sotgia et al.
JNM 2008;49:1090-1096.
ABSTRACT | FULL TEXT  

A novel mouse model of X-linked cardiac hypertrophy
Leatherbury et al.
Am. J. Physiol. Heart Circ. Physiol. 2008;294:H2701-H2711.
ABSTRACT | FULL TEXT  

The 2006 American Heart Association Classification of Cardiomyopathies Is the Gold Standard
Maron
Circ Heart Fail 2008;1:72-76.
FULL TEXT  

Oral Disopyramide for the Acute Treatment of Severe Outflow Obstruction in Hypertrophic Cardiomyopathy in the ICU Setting
Sirak and Sherrid
Chest 2008;133:1243-1246.
ABSTRACT | FULL TEXT  

Disease-Modifying Mutations in Familial Hypertrophic Cardiomyopathy: Complexity From Simplicity
Hilfiker-Kleiner and Knoll
Circulation 2008;117:1775-1777.
FULL TEXT  

Severe Heart Failure and Early Mortality in a Double-Mutation Mouse Model of Familial Hypertrophic Cardiomyopathy
Tsoutsman et al.
Circulation 2008;117:1820-1831.
ABSTRACT | FULL TEXT  

Medical Conditions Affecting Sports Participation
Rice and and the Council on Sports Medicine and Fitness
Pediatrics 2008;121:841-848.
ABSTRACT | FULL TEXT  

Tissue Doppler imaging to predict clinical course of patients with hypertrophic cardiomyopathy
Bayrak et al.
Eur J Echocardiogr 2008;9:278-283.
ABSTRACT | FULL TEXT  

Lys184 deletion in troponin I impairs relaxation kinetics and induces hypercontractility in murine cardiac myofibrils
Iorga et al.
Cardiovasc Res 2008;77:676-686.
ABSTRACT | FULL TEXT  

Pathology of Cardiac Surgery
Padera and Schoen
Card Surg Adult 2008;3:111-178.
FULL TEXT  

Regional myocardial deformation in children with hypertrophic cardiomyopathy: morphological and clinical correlations
Ganame et al.
Eur Heart J 2007;28:2886-2894.
ABSTRACT | FULL TEXT  

Myosin regulatory light chain E22K mutation results in decreased cardiac intracellular calcium and force transients
Szczesna-Cordary et al.
FASEB J. 2007;21:3974-3985.
ABSTRACT | FULL TEXT  

Septal Myectomy After Previous Septal Artery Ablation in Hypertrophic Cardiomyopathy
ElBardissi et al.
Mayo Clin Proc. 2007;82:1516-1522.
ABSTRACT | FULL TEXT  

Electrocardiograms Should Be Included in Preparticipation Screening of Athletes
Myerburg and Vetter
Circulation 2007;116:2616-2626.
FULL TEXT  

Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy
McLeod et al.
Eur Heart J 2007;28:2583-2588.
ABSTRACT | FULL TEXT  

Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy
Daw et al.
Hum Mol Genet 2007;16:2463-2471.
ABSTRACT | FULL TEXT  

Gray zone problem in athletes
Kasikcioglu
Eur Heart J 2007;28:2415-2416.
FULL TEXT  

Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Maron et al.
JAMA 2007;298:405-412.
ABSTRACT | FULL TEXT  

Hypertrophic Cardiomyopathy, Sudden Death, and Implantable Cardiac Defibrillators: How Low the Bar?
Nishimura and Ommen
JAMA 2007;298:452-454.
FULL TEXT